1. Home
  2. RVP vs CLRB Comparison

RVP vs CLRB Comparison

Compare RVP & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Retractable Technologies Inc.

RVP

Retractable Technologies Inc.

N/A

Current Price

$0.61

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$1.39

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVP
CLRB
Founded
1994
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
24.5M
IPO Year
2000
2008

Fundamental Metrics

Financial Performance
Metric
RVP
CLRB
Price
$0.61
$1.39
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.50
AVG Volume (30 Days)
24.8K
★ 80.4K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $38,266,211.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.78
N/A
52 Week Low
$0.60
$1.34
52 Week High
$1.14
$5.07

Technical Indicators

Market Signals
Indicator
RVP
CLRB
Relative Strength Index (RSI) 28.48 19.38
Support Level $0.61 N/A
Resistance Level $0.74 $3.03
Average True Range (ATR) 0.02 0.16
MACD -0.01 -0.03
Stochastic Oscillator 7.29 9.88

Price Performance

Historical Comparison
RVP
CLRB

About RVP Retractable Technologies Inc.

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: